William Douglas Figg (W Douglas Figg, William D Figg)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 49

Top Topics

Antimicrobial Resistance

Prostate Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science translational medicine

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renee Maria Saliby, Ziwei Zhang, Rong Li, Yijia Jiang, Len Taing, Mark Awad, Cindy H Chau, James A Decaprio, William Douglas Figg, Tim F Greten, Aaron N Hata, F Stephen Hodi, Melissa E Hughes, Keith L Ligon, Nancy Lin, Kimmie Ng, Matthew G Oser, Catherine Meador, Heather A Parsons, Mark M Pomerantz, Arun Rajan, Jerome Ritz, Manisha Thakuria, Sara M Tolaney, Patrick Y Wen, Henry W Long, Jacob E Berchuck, Zoltan Szallasi, Toni K Choueiri, Matthew L Freedman
Liquid biopsy epigenomic profiling for cancer subtyping. Nature medicine (2023)
Michiyo Iba, Changyoun Kim, Somin Kwon, Marcell P Szabo, Liam Horan-Portelance, Cody J Peer, William Douglas Figg, Xylena Reed, Jinhui Ding, Seung-Jae Lee, Robert A Rissman, Mark R Cookson, Cassia Overk, Wolf Wrasidlo, Eliezer Masliah
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD. Science translational medicine 15 (695) (2023)
Sarah Jenkins, Wei Zhang, Seth M Steinberg, Darryl Nousome, Nicole Houston, Xiaolin Wu, Terri S Armstrong, Eric Burton, DeeDee K Smart, Ritu Shah, Cody J Peer, Brett Mozarsky, Oluwatobi Arisa, William Douglas Figg, Tito R Mendoza, Elizabeth Vera, Priscilla Kaliopi Brastianos, Scott L Carter, Mark R Gilbert, Carey K Anders, Roisin M Connolly, Carol Tweed, Karen Lisa Smith, Imran Khan, Stanley Lipkowitz, Patricia S Steeg, Alexandra S Zimmer
Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Melissa L Abel, Nobuyuki Takahashi, Cody J Peer, Christophe E Redon, Samantha Nichols, Rasa Vilimas, Min-Jung Lee, Min-Jung Lee, Meenakshi Shelat, Robbie Kattappuram, Linda Sciuto, Danielle Pinkiert, Chante Graham, Donna Butcher, Baktiar O Karim, Ajit Kumar Sharma, Justin Malin, Rajesh Kumar, Christopher W Schultz, Shubhank Goyal, Jaydira Del Rivero, Manan Krishnamurthy, Deep Upadhyay, Brett A Schroeder, Tristan M Sissung, Manoj Tyagi, Jung Kim, Yves Pommier, Mirit I Aladjem, Mark Raffeld, William Douglas Figg, Jane Trepel, Liqiang Xi, Parth Desai, Anish Thomas
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Melissa L Abel, Nobuyuki Takahashi, Cody J Peer, Christophe E Redon, Samantha Nichols, Rasa Vilimas, Min-Jung Lee, Min-Jung Lee, Meenakshi Shelat, Robbie Kattappuram, Linda Sciuto, Danielle Pinkiert, Chante Graham, Donna Butcher, Baktiar O Karim, Ajit Kumar Sharma, Justin Malin, Rajesh Kumar, Christopher W Schultz, Shubhank Goyal, Jaydira Del Rivero, Manan Krishnamurthy, Deep Upadhyay, Brett A Schroeder, Tristan M Sissung, Manoj Tyagi, Jung Kim, Yves Pommier, Mirit I Aladjem, Mark Raffeld, William Douglas Figg, Jane Trepel, Liqiang Xi, Parth Desai, Anish Thomas
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jerry T Wu, Adam Cheuk, Kristine Isanogle, Christina Robinson, Xiaohu Zhang, Michele Ceribelli, Erin Beck, Paul Shinn, Carleen Klumpp-Thomas, Kelli M Wilson, Crystal McKnight, Zina Itkin, Hiroshi Sotome, Hiroshi Hirai, Elizabeth Calleja, Volker Wacheck, Brad Gouker, Cody J Peer, Natalia Corvalan, David Milewski, Yong Y Kim, William Douglas Figg, Elijah F Edmondson, Craig J Thomas, Simone Difilippantonio, Jun S Wei, Javed Khan
Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma. Cancers 15 (16) (2023)
Sharyn D Baker, Susan E Bates, Gabriel A Brooks, William L Dahut, Robert B Diasio, Wafik S El-Deiry, William E Evans, William Douglas Figg, Daniel Louis Hertz, J Kevin Hicks, Suneel D Kamath, Pashtoon Murtaza Kasi, Todd C Knepper, Howard L McLeod, Peter H O'Donnell, Mary V Relling, Michelle A Rudek, Tristan M Sissung, D Max Smith, Alex Sparreboom, Sandra M Swain, Christine M Walko
DPYD Testing: Time to Put Patient Safety First. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Kristi Y Lee, Erica L Beatson, Seth M Steinberg, Cindy H Chau, Douglas K Price, William Douglas Figg
Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer. Journal of racial and ethnic health disparities (2023)
Austin Wesevich, Daniel A Goldstein, Koosha Paydary, Cody J Peer, William Douglas Figg, Mark J Ratain
Interventional pharmacoeconomics for immune checkpoint inhibitors through alternative dosing strategies. British journal of cancer (2023)
Sylvan C Baca, Ji-Heui Seo, Matthew P Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian, Gitanjali Lakshminarayanan, Miklos Diossy, Xintao Qiu, Talal El Zarif, Hunter Savignano, John Canniff, Ikenna Madueke, Renee Maria Saliby, Ziwei Zhang, Rong Li, Yijia Jiang, Len Taing, Mark Awad, Cindy H Chau, James A Decaprio, William Douglas Figg, Tim F Greten, Aaron N Hata, F Stephen Hodi, Melissa E Hughes, Keith L Ligon, Nancy Lin, Kimmie Ng, Matthew G Oser, Catherine Meador, Heather A Parsons, Mark M Pomerantz, Arun Rajan, Jerome Ritz, Manisha Thakuria, Sara M Tolaney, Patrick Y Wen, Henry W Long, Jacob E Berchuck, Zoltan Szallasi, Toni K Choueiri, Matthew L Freedman
Author Correction: Liquid biopsy epigenomic profiling for cancer subtyping. Nature medicine (2023)
Edjah K Nduom, John Glod, Desmond A Brown, Margaret Fagan, Mahalia Dalmage, John Heiss, Seth M Steinberg, Cody Peer, William Douglas Figg, Sadhana Jackson
Clinical protocol: Feasibility of evaluating abemaciclib neuropharmacokinetics of diffuse midline glioma using intratumoral microdialysis. PloS one 18 (9) (2023)
Michiyo Iba, Changyoun Kim, Somin Kwon, Marcell P Szabo, Liam Horan-Portelance, Cody J Peer, William Douglas Figg, Xylena Reed, Jinhui Ding, Seung-Jae Lee, Robert A Rissman, Mark R Cookson, Cassia Overk, Wolf Wrasidlo, Eliezer Masliah
Inhibition of p38α MAPK restores neuronal p38γ MAPK and ameliorates synaptic degeneration in a mouse model of DLB/PD. Science translational medicine 15 (695) (2023)
Katherine E Warren, Gilbert Vezina, Mark Krailo, Linda Springer, Allen Buxton, Cody J Peer, William Douglas Figg, Chris William-Hughes, Sandy Kessel, Maryam Fouladi, Amar J Gajjar, Daniel C Bowers
Phase II Randomized Trial of Lenalidomide in Children With Pilocytic Astrocytomas and Optic Pathway Gliomas: A Report From the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Cecilia Monge, Erica C Pehrsson, Changqing Xie, Austin G Duffy, Donna Mabry, Bradford J Wood, David E Kleiner, Seth M Steinberg, William Douglas Figg, Bernadette Redd, Anuradha Budhu, Sophie Wang, Mayank Tandon, Lichun Ma, Xin Wei Wang, Tim F Greten
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma. The oncologist 27 (3) (2022)
Tristan M Sissung, William Douglas Figg
Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted. Cancers 14 (5) (2022)
Ashlyn Parkhurst, Sabrina Z Wang, Tyler R Findlay, Kristen J Malebranche, Arman Odabas, Jesse Alt, Micah J Maxwell, Harpreet Kaur, Cody J Peer, William Douglas Figg, Katherine E Warren, Barbara S Slusher, Charles G Eberhart, Eric H Raabe, Jeffrey A Rubens
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors. Cell death & disease 13 (4) (2022)
Kevin C Conlon, Dionysios C Watson, Thomas A Waldmann, Antonio Valentin, Cristina Bergamaschi, Barbara K Felber, Cody J Peer, William Douglas Figg, E Lake Potter, Mario Roederer, Douglas G McNeel, John A Thompson, Sumati V Gupta, Rom S Leidner, Andrea Wang-Gillam, Nehal S Parikh, Debby Long, Sema Kurtulus, Lang Ho Lee, Niladri Roy Chowdhury, Florent Bender, George N Pavlakis
Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors. Journal for immunotherapy of cancer 9 (11) (2022)
Yang Li, Yan Jin, Hanieh Taheri, Keith T Schmidt, Alice A Gibson, Stefan A J Buck, Eric D Eisenmann, Ron H J Mathijssen, William Douglas Figg, Sharyn D Baker, Alex Sparreboom, Shuiying Hu
A Metabolomics Approach for Predicting OATP1B-Type Transporter-Mediated Drug-Drug Interaction Liabilities. Pharmaceutics 14 (9) (2022)
Keith T Schmidt, Fatima Karzai, Marijo Bilusic, Lisa M Cordes, Cindy H Chau, Cody J Peer, Susan Wroblewski, Alwin D R Huitema, Jan H M Schellens, James L Gulley, William L Dahut, William Douglas Figg, Ravi A Madan
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide. The oncologist 27 (9) (2022)
Daniel M Girardi, Scot A Niglio, Amir Mortazavi, Rosa Nadal, Primo Lara, Sumanta K Pal, Biren Saraiya, Lisa Cordes, Lisa Ley, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Diaz, Hadi Bagheri, Bernadette Redd, Seth M Steinberg, Rene Costello, Keith S Chan, Min-Jung Lee, Min-Jung Lee, Yunkai Yu, Sandeep Gurram, Heather J Chalfin, Vladimir Valera, William Douglas Figg, Maria J Merino, Antoun Toubaji, Howard Streicher, John J Wright, Elad Sharon, Howard L Parnes, Yang-Min Ning, Donald P Bottaro, Liang Cao, Jane B Trepel, Andrea B Apolo
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Kristi Y Lee, Cindy H Chau, Douglas K Price, William Douglas Figg
Drugging the undruggable: activity-based protein profiling offers opportunities for targeting the KLK activome. Cancer biology & therapy 23 (1) (2022)
John A Ligon, R Taylor Sundby, Mary Frances Wedekind Malone, Fernanda I Arnaldez, Jaydira Del Rivero, Lori S Wiener, Ramaprasad Srinivasan, Melissa Spencer, Amanda Carbonell, Haiyan Lei, Jack F Shern, Seth M Steinberg, William Douglas Figg, Cody J Peer, Sara M Zimmerman, Josquin Moraly, Xia Xu, Stephen Fox, King Chan, Michael I Barbato, Thorkell Andresson, Naomi Taylor, Karel Pacak, J Keith Killian, Eva Dombi, W Marston Linehan, Markku M Miettinen, Richard L Piekarz, Lee J Helman, Paul S Meltzer, Brigitte C Widemann, John W Glod
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-associated Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Katie E Hebron, Xiaolin Wan, Jacob S Roth, David J Liewehr, Nancy E Sealover, William J E Frye, Angela Kim, Stacey Stauffer, Olivia L Perkins, Wenyue Sun, Kristine A Isanogle, Christina M Robinson, Amy James, Parirokh Awasthi, Priya Shankarappa, Xiaoling Luo, Haiyan Lei, Donna Butcher, Roberta Smith, Elijah F Edmondson, Jin-Qiu Chen, Noemi Kedei, Cody J Peer, Jack F Shern, William Douglas Figg, Lu Chen, Matthew D Hall, Simone Difilippantonio, Frederic G Barr, Robert L Kortum, Robert W Robey, Angelina V Vaseva, Javed Khan, Marielle E Yohe
The combination of trametinib and ganitumab is effective in RAS-mutated PAX-fusion negative rhabdomyosarcoma models. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Natalia Garcia, Vanessa Del Pozo, Marielle E Yohe, Craig M Goodwin, Terry J Shackleford, Long Wang, Kunal Baxi, Yidong Chen, Anna T Rogojina, Sara M Zimmerman, Cody J Peer, William Douglas Figg, Myron S Ignatius, Kris C Wood, Peter J Houghton, Angelina V Vaseva
Vertical Inhibition of the RAF-MEK-ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma. Molecular cancer therapeutics (2021)
Amélie Vézina, Monica Manglani, DreeAnna Morris, Brandon Foster, Matthew McCord, Hua Song, Meili Zhang, Dionne Davis, Wei Zhang, Jessica Bills, Kunio Nagashima, Priya Shankarappa, Jessica Kindrick, Stuart Walbridge, Cody J Peer, William Douglas Figg, Mark R Gilbert, Dorian B McGavern, Leslie L Muldoon, Sadhana Jackson
Adenosine A2A Receptor Activation Enhances Blood-Tumor Barrier Permeability in a Rodent Glioma Model. Molecular cancer research : MCR 19 (12) (2021)
Jing Wu, Ying Yuan, Debra A Long Priel, Danielle Fink, Cody J Peer, Tristan M Sissung, Yu-Ting Su, Ying Pang, Guangyang Yu, Madison K Butler, Tito R Mendoza, Elizabeth Vera, Salman Ahmad, Christine Bryla, Matthew Lindsley, Ewa Grajkowska, Kelly Mentges, Lisa Boris, Ramya Antony, Nancy Garren, Christine Siegel, Nicole Lollo, Christine Cordova, Orwa Aboud, Brett J Theeler, Eric M Burton, Marta Penas-Prado, Heather E Leeper, Javier Gonzales, Terri S Armstrong, Katherine R Calvo, William Douglas Figg, Douglas B Kuhns, John I Gallin, Mark R Gilbert
Phase I Study of Zotiraciclib in Combination with Temozolomide for Patients with Recurrent High-grade Astrocytomas. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Jin Wang, Bertrand Z Yeung, M Guillaume Wientjes, Minjian Cui, Cody J Peer, Ze Lu, William Douglas Figg, Sukyung Woo, Jessie L-S Au
A Quantitative Pharmacology Model of Exosome-Mediated Drug Efflux and Perturbation-Induced Synergy. Pharmaceutics 13 (7) (2021)
Camille Tlemsani, Nobuyuki Takahashi, Lorinc Sandor Pongor, Vinodh N Rajapakse, Manoj Tyagi, Xinyu Wen, Grace-Ann Fasaye, Keith T Schmidt, Parth Desai, Chul Kim, Arun Rajan, Shannon Swift, Linda Sciuto, Rasa Vilimas, Santhana Webb, Samantha Nichols, William Douglas Figg, Yves Pommier, Kathleen Calzone, Seth M Steinberg, Jun S Wei, Udayan Guha, Clesson E Turner, Javed Khan, Anish Thomas
Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies. Science translational medicine 13 (578) (2021)
Keith T Schmidt, Cindy H Chau, Jonathan D Strope, Alwin D R Huitema, Tristan M Sissung, Douglas K Price, William Douglas Figg
Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models. Molecular cancer therapeutics 20 (5) (2021)
Jay-Hyun Jo, Catriona P Harkins, Nicole H Schwardt, Jessica A Portillo, null null, Matthew D Zimmerman, Claire L Carter, Md Amir Hossen, Cody J Peer, Eric C Polley, Veronique Anne Dartois, William Douglas Figg, Niki M Moutsopoulos, Julie A Segre, Heidi H Kong
Alterations of human skin microbiome and expansion of antimicrobial resistance after systemic antibiotics. Science translational medicine 13 (625) (2021)
David K Doan, Keith T Schmidt, Cindy H Chau, William Douglas Figg
Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease Management. Cancers 13 (9) (2021)
Keith T Schmidt, Alwin D R Huitema, Cindy H Chau, William Douglas Figg
Resistance to second-generation androgen receptor antagonists in prostate cancer. Nature reviews. Urology 18 (4) (2021)
Andrea M Gross, Pamela L Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J Fisher, Brian Weiss, AeRang Kim, Miriam Bornhorst, Amish C Shah, Staci Martin, Marie C Roderick, Dominique C Pichard, Amanda Carbonell, Scott M Paul, Janet Therrien, Oxana Kapustina, Kara Heisey, D Wade Clapp, Chi Zhang, Cody J Peer, William Douglas Figg, Malcolm Smith, John Glod, Jaishri O Blakeley, Seth M Steinberg, David J Venzon, L Austin Doyle, Brigitte C Widemann
Selumetinib in Children with Inoperable Plexiform Neurofibromas. The New England journal of medicine 382 (15) (2020)
Keith T Schmidt, Alwin D R Huitema, Thomas P C Dorlo, Cody J Peer, Lisa M Cordes, Linda Sciuto, Susan Wroblewski, Yves Pommier, Ravi A Madan, Anish Thomas, William Douglas Figg
Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors. Cancer chemotherapy and pharmacology 86 (4) (2020)
Emily N Risdon, Cindy H Chau, Douglas K Price, A Oliver Sartor, William Douglas Figg
PARP Inhibitors and Prostate Cancer: To Infinity and Beyond BRCA. The oncologist 26 (1) (2020)
Cindy H Chau, Jonathan D Strope, William Douglas Figg
COVID-19 Clinical Diagnostics and Testing Technology. Pharmacotherapy 40 (8) (2020)
Tristan M Sissung, Lisa M Cordes, Cody J Peer, Shruti Gandhy, Jason Mark Redman, Julius Strauss, William Douglas Figg
Case report: severe toxicity in an African-American patient receiving FOLFOX carrying uncommon allelic variants in DPYD. Pharmacogenomics 22 (2) (2020)
Christina Ross, Karol Szczepanek, Maxwell Lee, Howard H Yang, Cody J Peer, Jessica Kindrick, Priya Shankarappa, Zhi-Wei Lin, Jack D Sanford, William Douglas Figg, Kent W Hunter
Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures. Molecular cancer research : MCR 18 (9) (2020)
Megan L Peach, Shaunna L Beedie, Cindy H Chau, Matthew K Collins, Suzana Markolovic, Weiming Luo, David Tweedie, Christian Steinebach, Nigel H Greig, Michael Gütschow, Neil Vargesson, Marc C Nicklaus, William Douglas Figg
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide Analogs. Molecules (Basel, Switzerland) 25 (23) (2020)
Eleanor Jing Yi Cheong, Pramod C Nair, Rebecca Wan Yi Neo, Ho Thanh Tu, Fu Lin, Edmund Chiong, Kesavan Esuvaranathan, Hao Fan, Russell Z Szmulewitz, Cody J Peer, William Douglas Figg, Christina Li Lin Chai, John O Miners, Eric Chun Yong Chan
Slow-, Tight-Binding Inhibition of CYP17A1 by Abiraterone Redefines Its Kinetic Selectivity and Dosing Regimen. The Journal of pharmacology and experimental therapeutics 374 (3) (2020)
Chandra Kumar Elechalawar, Md Nazir Hossen, Priya Shankarappa, Cody J Peer, William Douglas Figg, J David Robertson, Resham Bhattacharya, Priyabrata Mukherjee
Targeting Pancreatic Cancer Cells and Stellate Cells Using Designer Nanotherapeutics in vitro. International journal of nanomedicine 15 (2020)
Bih-Rong Wei, Shelley B Hoover, Cody J Peer, Jennifer E Dwyer, Hibret A Adissu, Priya Shankarappa, Howard H Yang, Maxwell Lee, Tyler J Peat, William Douglas Figg, R Mark Simpson
Efficacy, Tolerability, and Pharmacokinetics of Combined Targeted MEK and Dual mTORC1/2 Inhibition in a Preclinical Model of Mucosal Melanoma. Molecular cancer therapeutics 19 (11) (2020)
Roberto H Barbier, Cindy H Chau, William Douglas Figg
Androgen receptor splice variant 7 (AR-V7) and AR full-length (AR-FL) as predictive biomarkers of therapeutic resistance: partners in crime? BJU international 124 (4) (2019)
Kristin C Hicks, Karin M Knudson, Karin L Lee, Duane H Hamilton, James W Hodge, William Douglas Figg, Peter Ordentlich, Frank R Jones, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom, Sofia R Gameiro
Cooperative Immune-Mediated Mechanisms of the HDAC Inhibitor Entinostat, an IL15 Superagonist, and a Cancer Vaccine Effectively Synergize as a Novel Cancer Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (3) (2019)
Ramya Ramaswami, Thomas S Uldrick, Mark N Polizzotto, Kathleen M Wyvill, Priscila Goncalves, Anaida Widell, Kathryn Lurain, Seth M Steinberg, William Douglas Figg, Giovanna Tosato, Nazzarena Labo, Robert Yarchoan
A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (14) (2019)
Kevin C Conlon, E Lake Potter, Stefania Pittaluga, Chyi-Chia Richard Lee, Milos D Miljkovic, Thomas A Fleisher, Sigrid Dubois, Bonita R Bryant, Michael Petrus, Liyanage P Perera, Jennifer Hsu, William Douglas Figg, Cody J Peer, Joanna H Shih, Jason L Yovandich, Stephen P Creekmore, Mario Roederer, Thomas A Waldmann
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (16) (2019)
Laetitia Marzi, Keli Agama, Junko Murai, Simone Difilippantonio, Amy James, Cody J Peer, William Douglas Figg, Daniel Beck, Mohamed S A Elsayed, Mark Cushman, Yves Pommier
Novel Fluoroindenoisoquinoline Non-Camptothecin Topoisomerase I Inhibitors. Molecular cancer therapeutics 17 (8) (2018)
Emily M Harris, Jonathan D Strope, Shaunna L Beedie, Phoebe A Huang, Andrew K L Goey, Kristina M Cook, Christopher J Schofield, Cindy H Chau, Melissa M Cadelis, Brent R Copp, Kirk R Gustafson, William Douglas Figg
Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models. Marine drugs 16 (7) (2018)
Tristan M Sissung, Cody J Peer, Neha Korde, Sham Mailankody, Dickran Kazandjian, David J Venzon, Ola Landgren, William Douglas Figg
Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms. Cancer chemotherapy and pharmacology 80 (1) (2017)